• CRANBLISS SYRUP

  CRANBLISS SYRUP

  CRANBLISS TABLET

COMPOSITION:

Each 15 ml contains Cranberry extract (25% Proanthocyanidin) 200 mg, D-Mannose 300 mg & Potassium Magnesium Citrate 978 mg.

FORMULATION:

ORAL LIQUID

STATUS:

PRESCRIPTION ONLY DRUG

DESCRIPTION:

Cranbliss acts by preventing the stickiness of pathogen to the inner urinary tracts thereby preventing infection. Cranbliss is used with association of other medications for the management of Primary & Recurrent UTIs. It is also used for the prevention of UTI management.

SIDE EFFECTS:

Stomach or abdominal upset, Diarrhoea & Nausea.

DOSAGE/DIRECTIONS FOR USE:

As Prescribed by Physician